Medical Developments International Limitedの主要な財務諸表は何ですか?
MDDVFの主要な財務比率は何ですか?
Medical Developments International Limitedの収益はセグメントまたは地域別にどのように分けられていますか?
Medical Developments International Limitedは収益を上げていますか?
Medical Developments International Limitedに負債はありますか?
Medical Developments International Limitedの発行済株式数は何株ですか?
主要データ
前終値
$0.3706
始値
$0.3038
当日レンジ
$0.3038 - $0.3706
52週レンジ
$0.248 - $0.5076
取引高
173
平均取引高
139
1株当たり利益(TTM)
0.00
配当利回り
--
時価総額
$41.7M
Medical Developments Internatioとは何ですか?
Medical Developments International Ltd. engages in the manufacture and distribution of pharmaceutical drugs, medical, and veterinary equipment. The firm operates in two segments: Pain Management and Respiratory. The Pain Management segment is engaged in the supply of analgesia for acute and procedural pain. The firm manufactures inhaled analgesic, Penthrox (the Green Whistle), at manufacturing facilities at Scoresby and Springvale in Victoria, Australia. Penthrox is sold into domestic and international markets through distribution partnerships and direct in-market capability. The Respiratory segment is a supplier of respiratory products including asthma and chronic obstructive pulmonary disease (COPD) space chambers, peak flow meters, portable nebulizers and silicone face masks. Respiratory supplies into Australia, the United States of America, Europe, and Asia through partnerships with distributors.